CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $247,000 | -19.5% | 110,614 | -10.2% | 0.25% | -11.5% |
| Q2 2022 | $307,000 | -43.5% | 123,148 | +10.7% | 0.28% | -25.1% |
| Q1 2022 | $543,000 | -23.0% | 111,259 | +78.6% | 0.37% | -19.9% |
| Q4 2021 | $705,000 | -6.5% | 62,295 | +20.3% | 0.46% | -3.5% |
| Q3 2021 | $754,000 | +34.9% | 51,766 | +8.0% | 0.48% | +34.5% |
| Q2 2021 | $559,000 | +7.3% | 47,953 | +12.3% | 0.36% | +1.1% |
| Q1 2021 | $521,000 | -25.7% | 42,702 | -23.8% | 0.35% | -24.2% |
| Q4 2020 | $701,000 | – | 56,035 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |